Discounted Cash Flow
Bausch Health Companies Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $9.7b | $-2.4b | $1.9b | -24.9% | $-6.94 |
| 2017 | $8.7b (-9.8%) | $2.4b (199.8%) | $2.1b (14.4%) | 27.6% (210.7%) | $6.86 (198.8%) |
| 2018 | $8.4b (-3.9%) | $-4.1b (-272.5%) | $1.3b (-36.6%) | -49.5% (-279.6%) | $-11.81 (-272.2%) |
| 2019 | $8.6b (2.6%) | $-1.8b (56.9%) | $1.2b (-8.4%) | -20.8% (58.0%) | $-5.08 (57.0%) |
| 2020 | $8.0b (-6.7%) | $-560.0m (68.7%) | $809.0m (-34.3%) | -7.0% (66.4%) | $-1.58 (68.9%) |
| 2021 | $8.4b (5.1%) | $-948.0m (-69.3%) | $1.2b (43.0%) | -11.2% (-61.1%) | $-2.64 (-67.1%) |
| 2022 | $8.1b (-3.7%) | $-225.0m (76.3%) | $-946.0m (-181.8%) | -2.8% (75.4%) | $-0.62 (76.5%) |
| 2023 | $8.8b (7.8%) | $-592.0m (-163.1%) | $817.0m (186.4%) | -6.8% (-144.1%) | $-1.62 (-161.3%) |
| 2024 | $9.6b (9.9%) | $-46.0m (92.2%) | $1.3b (54.2%) | -0.5% (92.9%) | $-0.13 (92.0%) |
| 2025 | $10.3b (6.7%) | $157.0m (441.3%) | $1.0b (-20.4%) | 1.5% (420.0%) | $0.42 (423.1%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.